Fig. 3From: Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarctionPrimary endpoint risk in the study groups, after propensity score matching. Odds ratio and 95% confidence interval of the primary endpoint (composite of in-hospital mortality, acute heart failure, and acute kidney injury requiring renal replacement therapy) between the study groups, after propensity score matching. *OR was adjusted for chronic anti-hyperglycemic therapy. CI confidence interval, DM diabetes mellitus, GLP-1 RA glucagon-like peptide-1 receptor agonists, OR odds ratio, SGLT-2i sodium glucose cotransporter-2 inhibitorsBack to article page